Publication | Closed Access

Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial

Neuro-oncologySuperselective Intraarterial BevacizumabStrokeMedicineBrain InjuryNeurologyHigh-grade GliomasBrain LesionCerebral Blood FlowRadiation OncologyOncologyGliomaCerebral Vascular RegulationHealth Sciences